LianBio Shares Outstanding History (LIANY)
LianBio reported 107.0M shares outstanding at the end of fiscal 2022.
View full LianBio company overviewLianBio annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | 107.0M | −231,534 | −0.22% |
| 2021 | 2021-12-31 | 107.3M | 86.8M | +423.87% |
| 2020 | 2020-12-31 | 20.5M | — | — |
LianBio quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2023 | 2023-09-30 | 107.2M | −1.2M | −1.09% |
| Q2 2023 | 2023-06-30 | 107.2M | −1.2M | −1.09% |
| Q1 2023 | 2023-03-31 | 107.2M | −111,283 | −0.10% |
| Q4 2022 | 2022-12-31 | 107.0M | −231,534 | −0.22% |
| Q3 2022 | 2022-09-30 | 108.4M | 86.6M | +397.33% |
| Q2 2022 | 2022-06-30 | 108.4M | — | — |
| Q1 2022 | 2022-03-31 | 107.3M | — | — |
| Q4 2021 | 2021-12-31 | 107.3M | 86.8M | +423.87% |
| Q3 2021 | 2021-09-30 | 21.8M | — | — |
| Q4 2020 | 2020-12-31 | 20.5M | — | — |
LianBio shares outstanding trends
Between the periods ended 2020-12-31 and 2022-12-31, LianBio's shares outstanding moved from 20.5M to 107.0M, a change of 86.6M. The latest reported quarter, Q3 2023, shows 107.2M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LianBio source filings ↗